Position in ACHV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$588,000
-$480,038 QoQ
Shares Held
200,000
-6.9% QoQ
Ownership
0.194%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026683 Capital Management, LLC holds $349,034,024 across 34 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANAB |
Anaptysbio, Inc
|
660,000 | $44,550,000 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
290,000 | $35,548,200 | |
| 3 | MGTX |
MeiraGTx Holdings plc
|
2,300,000 | $31,073,000 | |
| 4 | WVE |
Wave Life Sciences, Inc.
|
4,950,000 | $28,759,500 | |
| 5 | QURE |
uniQure N.V.
|
575,000 | $26,484,500 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
389,081 | $21,376,110 | |
| 7 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,072,500 | |
| 8 | TRAX |
First Tracks Biotherapeutics, Inc.
|
750,000 | $15,090,000 |
All Filings in ACHV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $588,000 | 200,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,068,038 | 214,897 | Shares | Defined | 2026-02-17 | |
| 2022-09-30 | $412,500 | 125,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $610,000 | 125,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $946,250 | 125,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $972,500 | 125,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,062,500 | 125,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,122,500 | 125,000 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||